Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Total Non-Current Liabilities (2019 - 2023)

Alx Oncology Holdings' Total Non-Current Liabilities history spans 5 years, with the latest figure at $44.7 million for Q3 2023.

  • For Q3 2023, Total Non-Current Liabilities rose 77.15% year-over-year to $44.7 million; the TTM value through Sep 2023 reached $44.7 million, up 77.15%, while the annual FY2022 figure was $37.7 million, 146.58% up from the prior year.
  • Total Non-Current Liabilities for Q3 2023 was $44.7 million at Alx Oncology Holdings, up from $27.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $44.7 million in Q3 2023 and bottomed at $6.2 million in Q4 2020.
  • The 5-year median for Total Non-Current Liabilities is $15.3 million (2021), against an average of $20.0 million.
  • The largest annual shift saw Total Non-Current Liabilities plummeted 40.37% in 2020 before it soared 146.58% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $10.4 million in 2019, then tumbled by 40.37% to $6.2 million in 2020, then surged by 146.53% to $15.3 million in 2021, then skyrocketed by 146.58% to $37.7 million in 2022, then increased by 18.57% to $44.7 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Total Non-Current Liabilities are $44.7 million (Q3 2023), $27.1 million (Q2 2023), and $31.3 million (Q1 2023).